tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Financial Statements

Compare
1,281 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently $347.94M. The company's EPS TTM is $-3.036; its P/E ratio is ―; Solid Biosciences is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 8.09M$ 13.62M$ 0.00
Gross Profit$ 0.00$ -76.56M$ 5.69M$ -45.12M$ -3.92M
Operating Income$ -129.73M$ -104.31M$ -106.45M$ -72.25M$ -88.41M
EBITDA$ -129.73M$ -93.43M$ -96.87M$ -69.29M$ -84.37M
Net Income$ -124.70M$ -96.02M$ -65.51M$ -72.12M$ -90.12M
Balance Sheet
Cash & Short-Term Investments$ 148.92M$ 123.64M$ 213.72M$ 207.78M$ 154.74M
Total Assets$ 188.66M$ 164.94M$ 260.25M$ 232.38M$ 171.17M
Total Debt$ 24.18M$ 26.27M$ 28.55M$ 2.06M$ 5.15M
Net Debt$ -56.06M$ -47.75M$ -126.84M$ -117.07M$ -149.59M
Total Liabilities$ 51.42M$ 38.46M$ 48.59M$ 24.17M$ 39.08M
Stockholders' Equity$ 137.25M$ 126.48M$ 211.67M$ 208.21M$ 132.09M
Cash Flow
Free Cash Flow$ -100.67M$ -95.69M$ -100.99M$ -79.05M$ -57.50M
Operating Cash Flow$ -100.01M$ -94.18M$ -97.98M$ -77.76M$ -56.60M
Investing Cash Flow$ -16.09M$ 9.69M$ 59.16M$ -91.09M$ 6.60M
Financing Cash Flow$ 122.44M$ 3.12M$ 74.83M$ 134.99M$ 128.70M
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis